The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.

Federal regulators announced a settlement Wednesday with Express Scripts to change how the company handles prescription drug ...

The MarketWatch News Department was not involved in the creation of this content. Settlement resolves FTC lawsuit alleging that Express Scripts' conduct resulted in artificially inflated insulin drug ...

The Federal Trade Commission has reached a proposed settlement with CVS Caremark, one of the largest pharmacy benefit ...

The Federal Trade Commission reached a settlement with Cigna’s Express Scripts in a case over alleged inflation of insulin prices, according to a Feb. 4 agency news release. With the move, the FTC ...

Reforming the prescription system could lead to major savings for patients, with one report putting the number as high as ...